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Summary
Objective: Post-proliferative chondrocytes in growth cartilage are present in two forms, light and dark cells. These cells undergo hypertrophy
and die by a mechanism that is morphologically distinct from apoptosis, but has not been characterized. The aims of the current study were to
document the ultrastructural appearance of dying hypertrophic chondrocytes, and to establish a culture system in which the mechanism of
their death can be examined.
Design: Growth cartilage from fetal and growing postnatal horses was examined by electron microscopy. Chondrocytes were isolated from
epiphyseal cartilage from fetal horses and grown in pellet culture, then examined by light and electron microscopy, and quantitative polymer-
ase chain reaction.
Results: In tissue specimens, it was observed that dying dark chondrocytes underwent progressive extrusion of cytoplasm into the extracellular
space, whereas light chondrocytes appeared to disintegrate within the cellular membrane. Pellets cultured in 0.1% fetal calf serum (FCS) contained
dying light and dark chondrocytes similar to those seen in vivo.Transforming growth factor-b1 or 10%FCS increased the proportion of dark cells and
inducedcell death.Triiodothyronine increased thedifferentiationofdarkand light cellsand induced their death.Dark cellswereassociatedwithhigher
levels of matrix metalloproteinase-13 expression than light cells, and light cells were associated with higher levels of type II collagen expression.
Conclusions: Light and dark hypertrophic chondrocytes each undergo a distinctive series of non-apoptotic morphological changes as they die.
Pellet culture can be used as a model of the two forms of physiological death of hypertrophic chondrocytes.
ª 2006 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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SocietyIntroduction
During development and growth of the skeleton, the carti-
lage models of long bones are gradually replaced by bone
tissue through the process of endochondral ossiﬁcation.
The formation of primary and then later secondary centers
of ossiﬁcation leads to the existence of growth cartilage
in two locations: the physeal growth cartilage (PGC) or
growth plate, which gives rise to metaphyseal bone, and
the articulareepiphyseal growth cartilage (AEGC), which
gives rise to epiphyseal bone. Chondrocytes in both of
these locations undergo an orderly series of functional
changes that allow the growth cartilage to drive longitudinal
bone growth while producing a transient matrix that pro-
vides an appropriate level of structural support. Following
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hypertrophy and then die, before the cartilage matrix that
they have synthesized is invaded by osteoclasts and blood
vessels, which prepare the tissue for ossiﬁcation.
Physiological (or programmed) cell death in vivo can oc-
cur in many different ways, which have been subjected to
a variety of classiﬁcation systems by different authors1e3.
The most studied forms of physiological cell death are apo-
ptosis and autophagic cell death4,5. The typical features of
these two forms of death and of the pathological form of
death known as necrosis are summarized in Table I, part A.
A dominant feature of apoptosis is intense chromatin con-
densation, whereas autophagic cell death is characterized
by the presence of numerous autophagosomes. In the clas-
siﬁcation system developed by Schweichel and Merker1 in
1973, dying hypertrophic chondrocytes were presented as
an example of a third mode of cell death distinct from apo-
ptosis and autophagic cell death; this paper continues to be
cited in reviews of physiological cell death, referring to
a mode of death (‘non-lysosomal degradation’) that remains
uncharacterized6. Despite this, chondrocytes in growth car-
tilage are often described as dying by apoptosis, largely on
the basis of detection of DNA strand breaks using the TU-
NEL method, or other molecular features known to be asso-
ciated with apoptosis7,8. The deﬁnitive identiﬁcation of
apoptosis is, however, morphological9. In a series of recent
papers including both presentation of primary data and crit-
ical reviews of the relevant literature, Roach and colleagues
observed that ultrastructural studies of dying hypertrophic
chondrocytes fail to identify cells with the typical features5
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Summary of morphological characteristics of different forms of cell death
Part A* Part By
Apoptosis Autophagic
cell death
Necrosis Dark cell death Light cell
death
Nuclear
chromatin
Condensed into
sharply
circumscribed
round or crescent
masses at margin
of nuclear
membrane
Condensed into
single pyknotic
mass in center
of nucleus
Moderately
condensed in
irregular
aggregates
Condensed into
irregular patches
throughout
nucleus
Chromatin
condensation
inconsistent.
Nuclear
appearance
varies from pale
to uniformly
condensed
Nuclear
membrane
Progressively
convoluted;
initially well
preserved, later
discontinuous
Well preserved Ruptured Well preserved;
often convoluted
Well preserved
Cytoplasm Condensed; well
preserved
organelles
compacted
together
Contains
numerous
autophagocytic
vacuoles
Cytoplasm and
organelles
grossly swollen
and vacuolated
Cytoplasm
condensed; often
contains distended
RER; gradually
extruded into
extracellular space
Cytoplasm and
organelles
progressively
disintegrate
Cell
membrane
Well preserved;
often convoluted
Well preserved Ruptured early Extruded with
cytoplasm
Appears well
preserved
Final stage Nucleus and
cytoplasm
fragmented into
membrane-bound
apoptotic bodies
Organelles
degraded
(amorphous
cytoplasm);
compacted
nucleus
Cytoplasm and
organelles
disintegrated;
chromatin
degraded
(nuclear ghost)
Cytoplasm and
nucleus
fragmented
Cytoplasm and
nucleus
fragmented
Timing of
nuclear and
cytoplasmic
changes
Nuclear changes
precede
cytoplasmic
alterations
Cytoplasmic
changes
precede nuclear
alteration
Cytoplasmic
changes
precede nuclear
alterations
Cytoplasmic
changes precede
nuclear alterations
Cytoplasmic
changes precede
nuclear
alterations
*Reviewed in Refs. 4 and 35.
yNew observations presented in the current manuscript.of apoptosis: condensation of chromatin into geometric pat-
terns, nuclear fragmentation and cell shrinkage10e12. Sha-
piro et al.13 have contributed to the debate in a review
putting forward the hypothesis that hypertrophic chondro-
cytes die by autophagic cell death.
Previous ultrastructural studies of growth cartilage have
provided a variety of morphological descriptions of dying hy-
pertrophic chondrocytes1,10e12,14,15. These studies have
been conducted on samples obtained from different spe-
cies, locations and developmental stages, and a variety of
terminology has been used to describe the morphology of
these cells as they die. Thus, although it is now clear that
these cells do not undergo apoptosis in vivo, it is difﬁcult
to obtain from published literature a systematic spatiotem-
poral picture of the morphology of dying hypertrophic chon-
drocytes, and without this it is not possible to address the
mechanistic question of how these cells die.
A fact which has received little attention in recent studies
of growth cartilage, and which may complicate the under-
standing of how hypertrophic chondrocytes die, is the
co-existence of two morphologically distinct types of chon-
drocytes (‘light’ and ‘dark’) in zones of proliferation and
hypertrophy14,16,17. Light chondrocytes are usually oval or
round cells with a few thin cytoplasmic processes extending
into the surrounding matrix; the cytoplasm contains sparse
endoplasmic reticulum and an inconspicuous Golgi region.
Dark chondrocytes are of an irregular shape with numerousdense cytoplasmic processes and vesicles budding from
the cell surface; the cytoplasm contains well developed en-
doplasmic reticulum and a prominent Golgi zone consisting
of numerous vacuoles ﬁlled with ﬁbrillar material. No infor-
mation is available about molecular differences between
light and dark chondrocytes. Distinct light and dark chondro-
cytes have not been described in mature cartilage.
The current study had three aims: to obtain a systematic
overview of the morphology of dying hypertrophic chon-
drocytes by examining these cells in PGC and AEGC
from different bones throughout the development and
growth in a single large mammalian species; to develop
a culture system in which the mechanism of physiological
death of hypertrophic chondrocytes could be studied; and
to investigate factors regulating physiological death of
these cells.
Materials and methods
REAGENTS
DMEM, gentamicin, amphotericin B, L-glutamine and fetal
calf serum (FCS) were obtained from Invitrogen. Recombi-
nant human TGF-b1 was from R&D Systems, collagenase
A from Roche and staurosporine from Alexis Biochemicals.
Triiodothyronine (T3) and L-ascorbic acid were from
SigmaeAldrich.
577Osteoarthritis and Cartilage Vol. 15, No. 5SPECIMEN COLLECTION AND PROCESSING FOR LIGHT
AND ELECTRON MICROSCOPY
Tissue specimens from fetal horses were obtained from
a local abattoir; stage of gestation was estimated on the ba-
sis of crown:rump length18. Postnatal equine specimens
were obtained from the abattoir or from animals that died
from disease unrelated to the skeleton at the University of
Melbourne Veterinary Clinic and Hospital. Fetal specimens
were obtained from animals at the third, sixth, ninth and
tenth month of gestation (referred to as F3, etc.), and post-
natal specimens were obtained from animals of 6 months
of age. Specimens were collected from the AEGC and
PGC of the proximal end of the humerus and tibia and distal
end of the femur. Cartilage with some adjacent bone was
excised and ﬁxed in 5% glutaraldehyde/4% paraformalde-
hyde in 0.1 M cacodylate at 4C. The specimens were de-
calciﬁed in 0.33 M ethylene-diamine-tetra-acetic acid
(EDTA). Specimens prepared by the standard method
were postﬁxed in 1% osmium tetroxide/1.5% potassium-
ferrocyanide19 and embedded in Spurr’s resin. For proteo-
glycan staining20, after ﬁxation and decalciﬁcation some
specimens were stained en bloc with 0.1% safranin-O and
postﬁxed in 1% osmium tetroxide/0.25% safranin-O before
being embedded in Spurr’s resin. Semi-thin sections for
light microscopy were stained with methylene blue. Ultrathin
sections of all specimens were stained with uranyl acetate
and Reynold’s stain and were examined under a transmis-
sion electron microscope (Philips 300).
CHONDROCYTE ISOLATION AND CULTURE
Metacarpophalangeal joints of prenatal foals (of various
ages) were opened under aseptic conditions and the carti-
lage of the epiphyses excised. In some specimens the sec-
ondary center of ossiﬁcation had not yet formed, and in
others it was present. In each case the excised cartilage in-
cluded the articular surface, and excluded any bone tissue
and the zone of hypertrophy; it contained primarily resting,
pre-proliferative chondrocytes. The specimens were dis-
sected into small pieces, and chondrocytes were obtained
by overnight digestion of the cartilage in 0.5% collagenase
diluted in DMEM containing 1% FCS at 37C, then cultured
in pellets using a modiﬁcation of the method of Kato et al.21.
Brieﬂy, 5 105 cells were placed into 15 ml polypropylene
tubes in 1 ml aliquots of DMEM containing gentamicin
(50 mg/ml), amphotericin B (2.5 mg/ml), L-glutamine
(300 mg/ml), L-ascorbic acid (50 mg/ml) and 0.1% or 10%
FCS. The cells were centrifuged to form pellets and then
maintained at 37C with the caps of the tubes closed. After
48 h, the cells formed disc-like pellets that could be manip-
ulated with forceps. Pellets were harvested and ﬁxed at 0,
7, 14, 21 and 28 days. In some experiments, TGF-b1
(10 ng/ml) or T3 (100 ng/ml) was included in the medium
containing FCS (10% or 0.1%) from day 7 until day 28. In
another experiment, pellets were cultured for 20 days
in 0.1% FCS, then staurosporine (1 mM) was added to the
medium of some pellets prior to harvest 24 h later. The pel-
lets were ﬁxed in cold 2.5% glutaraldehyde/4% paraformal-
dehyde in 0.1 M cacodylate and processed for light and
electron microscopy as described for tissue specimens.
Some cells were cultured in monolayer in 25 cm2 ﬂasks
instead of pellet culture. These cells were grown to conﬂu-
ence in DMEM (containing10% FCS and all additives as for
pellet culture except L-ascorbic acid), then treated with 0.1%
FCS for 24 h. Cultures were then treated with or without
staurosporine (1 mM) in DMEM containing 0.1% FCS for24 h. The cells were trypsinised and centrifuged; the pellets
were ﬁxed and processed for light and electron microscopy
as described for tissue specimens.
CELL COUNTS
Counting of light and dark chondrocytes and chondro-
cytes undergoing different forms of physiological death
was undertaken using semi-thin sections of pellets stained
with methylene blue. Digital images were captured and total
cells counted manually. Following extensive comparison of
light and electron micrographs of the same specimens, it
was possible to identify light and dark cells, and cells dying
with the typical features of dying light or dark cells in vivo, or
undergoing apoptosis, on the basis of cell morphology in
semi-thin sections (see criteria listed in Table I). These
cell types were counted by eye and expressed as a percent-
age of total cells. Results are presented as mean S.E.M.
(n  3). Statistical differences between groups were evalu-
ated using a one-way ANOVA with a Bonferroni post-hoc
test; P values <0.05 were considered signiﬁcant.
QUANTITATIVE POLYMERASE CHAIN REACTION
Isolated chondrocytes were cultured as pellets in 0.1%
FCS until day 7, when they were treated with either T3
(100 ng/ml in 0.1% FCS) or 10% FCS. At day 21 or day
25, the pellets were collected and frozen in liquid nitrogen.
Some pellets were processed for histology to conﬁrm the
presence of hypertrophic dark and light chondrocytes. For
each treatment, three pools of at least 10 pellets were
used for RNA extraction. RNA was extracted using TRI
reagent (Sigma, St Louis, MO, USA) and further puriﬁed us-
ing the SV RNA Isolation Kit (Promega, Madison, WI, USA).
Reverse transcription was carried out using MMLV Reverse
Transcriptase RNase H-minus (Promega). Primers for
quantitative polymerase chain reaction (qPCR) were
designed as follows (numbers indicate exonic location of
primer): Ribosomal protein S23 (RP-S23) 1-Fwd: CAGAGT
GGCACGATAAGCAG, 2-Rev: CACACTTCCTGATGGCA
GAA; Type II Collagen 20-Fwd: CAGACGGGTGAACCTGG
TAT, 22-Rev: TCTCCACGAGCACCTCTTTT; Aggrecan 6-
Fwd: CTACGACGCCATCTGCTACA, 7-Rev: ACCGTCTG
GATGGTGATGTC; Runx2 4-Fwd: TCCCTGAACTCTGCA
CCAAG, 5-Rev: GCCAGGTAGGAGGGGTAAGA; Sox9 1-
Fwd: CCGAGCTCAGCAAGACTCTG, 2-Rev: CGCGGCTG
GTACTTGTAATC; Connective tissue growth factor (CTGF)
4-Fwd: GCAGGCTGGAAAGCAGAGC, 5-Rev: ATGTCTTC
ATGCTGGTGCAG (modiﬁed from published primers for hu-
man CTGF22); Vascular endothelial growth factor (VEGF)
1-Fwd: CTTGCCTTGCTGCTCTACCT, 3-Rev: GACGTCC
AGAACTTCACCA; Fibroblast growth factor receptor-3
(FGFR3) 7-Fwd: TCTATCGGGTTTTCCCATCA, 8-Rev AC
CACCAGGATGAAGAGGAG. Published primers for human
matrix metalloproteinase-13 (MMP-13) were used23. RP-
S23 was used as a housekeeping gene, as its expression
has been shown to be consistent in both the proliferating
and hypertrophic zones of the growth plate24. Automated
sequencing was carried out on all PCR products to conﬁrm
their identity (AGRF, Melbourne, Australia). Real-time
qPCR was performed using a Stratagene MX3000, using
Platinum SYBR Green qPCR Supermix UDG (Invitrogen,
Groningen, The Netherlands). Results for qPCR were
analyzed using the Pair-wise Fixed Reallocation Randomi-
zation Test from the Relative Expression Software Tool e
384, version 125. The results for each gene of interest nor-
malized to results for RP-S23 expression are presented as
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levels in T3-treated pellets, or vice versa, depending on
the treatment in which speciﬁc genes were more highly ex-
pressed (mean S.E.M.; n¼ 3).
Results
DEATH OF HYPERTROPHIC CHONDROCYTES IN VIVO
Ultrastructural studies were conducted on specimens of
growth cartilage (PGC and AEGC, where relevant) from
the humerus of fetal and postnatal horses ranging in age
from F3 to 6 months. In all specimens of growth cartilage
examined, light and dark chondrocytes (as described by
Hwang16), could be identiﬁed from the zone of cells that
had just undergone proliferation to the end of the zone of
hypertrophic chondrocytes (Fig. 1). Light and dark chondro-
cytes could not be distinguished in the resting zone (not
shown). The dark chondrocytes were characterized by elec-
tron dense cytoplasm containing abundant, often dilated,
rough endoplasmic reticulum [RER; Fig. 2(AeD)]. Light
chondrocytes, in contrast, were characterized by electron-
lucent cytoplasm that contained less developed RER
[Fig. 2(EeH)].
Both types of chondrocytes could be identiﬁed, each un-
dergoing a distinctive series of morphological changes,
from the zone of proliferation, through the zone of hypertro-
phy to the boneecartilage interface (Fig. 1). The dark chon-
drocytes gradually underwent condensation, but contained
RER and secretory vacuoles until the last few lacunae
before the boneecartilage interface [Fig. 2(AeD)]. The se-
cretory material contained abundant proteoglycan, as dem-
onstrated by safranin-O staining [Fig. 2(D)]. For these cells,
the process of dying involved progressive extrusion of their
cytoplasm with secretory contents into the extracellular
space. The nucleus underwent patchy chromatin condensa-
tion, without forming the intense geometric accumulations
of chromatin typical of apoptosis [Fig. 2(B, C)]. In contrast,
light chondrocytes appeared to disintegrate initially within
the cellular membrane [Fig. 2(EeH)]. Their nuclei were
pale and apparently functional, and the cytoplasm con-
tained RER and proteoglycan granules until the cytoplasm
had almost completely disintegrated [Fig. 2(EeH)]. Within
the last row of lacunae before the boneecartilage interface,
most lacunae only contained cell remnants [e.g., Figs. 1(A,
E) and 2(C, G)]. The morphological features observed for
dying hypertrophic light and dark chondrocytes are summa-
rized in Table I, part B.
The chondrocytes presented here are all from the proxi-
mal humeral PGC of fetal specimens. Although the depth
of growth cartilage varied with age and anatomical location,
the description of morphological changes of light and dark
chondrocytes during hypertrophy and death presented
above is generally relevant to all specimens examined.
AMETHODFOR INVESTIGATIONOFDEATHOFHYPERTROPHIC
CHONDROCYTES IN VITRO
Chondrocytes isolated from fetal equine growth cartilage
were cultured for up to 28 days in pellet culture under a va-
riety of culture conditions, and examined by light and elec-
tron microscopy. At day 0, pelleted cells appeared rounded
and closely packed, with no evidence of extracellular matrix.
By about 7 days, the cells had formed a semi-transparent
cartilage-like tissue, which continued to expand with time
in culture. Sections of pellets showed chondrocytes within
lacunae surrounded by a metachromatic extracellularmatrix. Most cells had the appearance of chondrocytes in
the resting zone of growth cartilage, and could not be iden-
tiﬁed as light or dark cells. Dark and light chondrocytes
could be distinguished by day 14, by which time some cells
appeared morphologically hypertrophic. At the later stages
of culture, cells showing the typical features of dying dark
and light chondrocytes, as seen in vivo, were present
[Fig. 3(A, D, E)]. In some cases a light and a dark chondro-
cyte were observed in the same lacuna [Fig. 3(C)]. Some
cells undergoing apoptosis were also seen, usually toward
the edges of the pellets, where the cells were ﬂattened
like cells in perichondrium; in some cases they were being
phagocytosed by adjacent cells [Fig. 3(B)].
REGULATION OF CHONDROCYTE DIFFERENTIATION
AND DEATH IN PELLET CULTURE
Chondrocyte pellet cultures were exposed to a variety of
conditions to determine whether the proportion of light and
dark cells could be regulated, and to investigate the regula-
tion of different forms of death. In pellets cultured in 10%
FCS, the majority (70e80%) of cells was dark chondrocytes
and very few light chondrocytes were detected [Fig. 4(A)]. In
pellets cultured in 0.1% FCS, there were more light than
dark chondrocytes identiﬁable, but a high proportion of
chondrocytes remained as resting cells, not distinguishable
as either light or dark [Fig. 4(A)]. An analysis of cell death
demonstrated that in pellets cultured in 10% FCS, at 21
days 30% of cells were dark cells undergoing the form of
death seen for these cells in vivo, no dying light cells
were detectable, and about 10% of cells were undergoing
apoptosis; by 28 days, some dying light cells (similar to
those seen in vivo) were detectable, but the vast majority
of dying cells was dark chondrocytes [Fig. 4(B)]. In pellets
cultured in 0.1% FCS, very few dying cells of any type (dy-
ing light cells, dying dark cells or apoptotic cells) were ob-
served [Fig. 4(B)] at any time point.
In pellets cultured in the presence of T3 in 0.1% FCS,
there were more light cells than dark cells. More light and
dark cells were seen at 21 days and 28 days than in pellets
cultured in 0.1% FCS alone [Fig. 4(C)], but at 28 days the
ratio of light:dark cells was similar for the two treatment
conditions (1.48 for T3-treated pellets and 1.69 for 0.1%
FCS-treated pellets). Moreover, treatment with T3 led to
the presence of increased percentages of dying light and
dark cells by day 28 [Fig. 4(D)]. In pellets treated with
TGF-b1 in the presence of 0.1% FCS, most cells were iden-
tiﬁable as dark cells by day 21 [Fig. 4(E)], and as dying dark
cells by day 28 [Fig. 4(F)].
In order to investigate molecular differences between light
and dark hypertrophic chondrocytes, expression of a number
of genes involved in regulation of chondrocyte behavior was
compared in pellets enriched in one or the other type of cell,
using qPCR. Pellets cultured in 10% FCS until day 21 (which
contained approximately 72% dark chondrocytes and 8%
light chondrocytes in an early stage of hypertrophy; ‘dark
cell-enriched cultures’) were compared with pellets cultured
in the presence of T3 (which contained approximately 32%
dark chondrocytes and 49% light chondrocytes in an early
stage of hypertrophy; ‘light cell-enriched cultures’). MMP-
13, VEGF, CTGF and Sox9 mRNA were signiﬁcantly more
highly expressed in dark cell-enriched than in light cell-
enriched cultures [Fig. 5(A)]. The highest level of relative ex-
pression was shown by MMP-13, which was 14-fold more
highly expressed in dark cell-enriched than light cell-
enriched cultures. Type II collagen was 7-fold more highly
expressed in light cell-enriched cultures than in dark
579Osteoarthritis and Cartilage Vol. 15, No. 5Fig. 1. Morphology of chondrocytes in growth cartilage from the proximal physis of the humerus of a 10-month equine fetus. A: Light micro-
graph; labels BeE indicate the regions corresponding to micrographs shown in parts BeE. BeE: Electron micrographs showing light (LI) and
dark (DA) chondrocytes in the zone of proliferation (B), the beginning of the zone of hypertrophy (C), the middle of the zone of hypertrophy (D),
and the last few lacunae before the ossiﬁcation front (E). Bar in A¼ 25 mm. The magniﬁcation for parts BeE is the same; bar¼ 10 mm.
580 Y. A. Ahmed et al.: Death of hypertrophic chondrocytesFig. 2. Morphology of dying hypertrophic chondrocytes. Electron micrographs of the proximal physis of the humerus of a 3-month (AeC, EeG)
or an 8-month (D, H) equine fetus. Sections in AeC and EeG were stained by the standard method, and sections in D, H were from tissues
stained en bloc with safranin-O. AeD: Hypertrophic dark chondrocytes in the early (A), middle (B) and late (C, D) stages of degeneration. The
nucleus (small arrows) shows progressive patchy chromatin condensation. Cytoplasm is progressively extruded into the extracellular space
581Osteoarthritis and Cartilage Vol. 15, No. 5Fig. 3. Chondrocyte hypertrophy and death in pellet culture. Light micrograph (A) and electron micrographs (BeE) of chondrocytes cultured as
pellets for 28 days in the presence of T3 in 0.1% FCS. A: Early (white arrow) and dying (white arrowhead) hypertrophic light chondrocytes, and
early (black arrow) and dying (black arrowhead) hypertrophic dark chondrocytes can be seen. B: An apoptotic cell from the periphery of the
pellet contains intensely condensed chromatin typical of apoptosis (arrow), and an adjacent cell has phagocytosed remnants of an apoptotic
cell (arrowhead). C: Recently proliferated light (LI) and dark (DA) chondrocytes within the same lacuna. D: A dying hypertrophic dark chon-
drocyte. E: A dying hypertrophic light chondrocyte. Bar in A¼ 25 mm. The magniﬁcation in parts BeE is the same; bar¼ 2 mm.cell-enriched cultures [Fig. 5(A)]. Pellets cultured in 10%
FCS until day 25 (which contained approximately 67% dying
dark chondrocytes and 2% dying light chondrocytes; ‘dying
dark cell-enriched cultures’) were compared with pellets cul-
tured in the presence of T3 for 25 days (which contained ap-
proximately 20% dying dark chondrocytes and 53% dying
light chondrocytes; ‘dying light cell-enriched cultures’). In
these cultures, the difference in CTGF (15-fold), VEGF (8-
fold) and MMP-13 (25-fold) expression between dying dark
cell-enriched and dying light cell-enriched cultures was
greater than for the early hypertrophic cultures, but Sox9
was no longer differentially expressed [Fig. 5(B)]. Type II col-
lagen and Runx2 were more highly expressed in dying light
cell-enriched cultures than in dying dark cell-enrichedcultures [Fig. 5(B)]. Aggrecan and FGFR3 were not differen-
tially expressed at either time point.
INDUCTION OF DEATH BY STAUROSPORINE IN
CHONDROCYTES IN MONOLAYER AND PELLET CULTURE
Chondrocytes grown in monolayer culture were exposed
to staurosporine for 24 h, and then examined by electron
microscopy. Staurosporine was found to induce apoptosis
in 43% of cells [Fig. 6(AeC)]. In contrast, in pellet culture,
staurosporine did not induce apoptosis, but rather death
of dark cells morphologically indistinguishable from that
seen in vivo [Fig. 6(DeF)].(arrowheads in AeD) until there is almost none left (C). RER (large arrows) is prominent at all stages, and a higher magniﬁcation (D) shows the
presence of vacuoles (V) containing proteoglycans. EeH: Hypertrophic light chondrocytes in the early (E), middle (F) and late (G, H) stages of
degeneration. The nucleus (small arrows) remains intact and apparently functional while the cytoplasm disintegrates within the cell membrane
(arrowhead in F). RER (large arrows) is visible at all stages, and safranin-O-positive proteoglycan particles (arrowheads) are seen within the
cell and in the surrounding matrix. The magniﬁcation in parts AeC and EeG is the same; all bars¼ 2 mm.
582 Y. A. Ahmed et al.: Death of hypertrophic chondrocytesFig. 4. Regulation of chondrocyte differentiation and death in pellet culture. Pellets were cultured in the presence of 10% or 0.1% FCS (A, B),
T3 or 0.1% FCS (control; C, D), or TGF-b1 or 0.1% FCS (control; E, F). A, C, E: after 21 (21 D) or 28 days (28 D), dark, light and resting
chondrocytes were counted and results expressed as a percentage of total cells. B, D, F: at the same time points, dying dark chondrocytes
(DDC), dying light chondrocytes (DLC) or apoptotic chondrocytes (APOP) were counted and results expressed as a percentage of total cells.
Data represent mean S.E.M. Signiﬁcant differences between values are expressed as follows: a e P< 0.001, b e P< 0.01, c e P< 0.05 for
comparison between treatment and control; d e P< 0.001, e e P< 0.01 for comparison between 21 D and 28 D.Discussion
The ﬁrst aim of the current study was to obtain a system-
atic overview of the morphology of dying hypertrophic chon-
drocytes across the spatiotemporal range of situations in
which they are found. This aim was achieved through the
demonstration that the two types of chondrocytes present
in growth cartilage undergo distinctive, non-apoptotic forms
of physiological death, as documented in Table I, part B.
The fact that chondrocytes in growth cartilage do not un-
dergo apoptosis has been clearly argued by Roach and
Clarke11 and does not need to be discussed further here.
The idea that light and dark chondrocytes represent differ-
ent cell types from the time of proliferation, each with its
own distinctive form of death, has however not previously
been proposed. Early ultrastructural studies that recognizedthe existence of light and dark chondrocytes did not specif-
ically address the question of how these cells died14,16.
Wilsman et al.14 provided an elegant description of ‘disinte-
grating’ light and dark cells, but suggested that these may
be different states of differentiation of one cell type. Roach
and Clarke11 provided a thorough characterization of the
process of death undergone by dark chondrocytes corre-
sponding to that observed in the current study, but paid
no attention to the process of death being undergone in par-
allel by adjacent light chondrocytes (described by these au-
thors as ‘hydrated’ cells).
As demonstrated here in Fig. 1, both light and dark cells
were observed from the zone of proliferation to the last lacu-
nae before the ossiﬁcation front, each undergoing its own
series of progressive changes during hypertrophy and
583Osteoarthritis and Cartilage Vol. 15, No. 5Fig. 5. Quantitative PCR analysis of mRNA expression in early (A) and dying (B) hypertrophic chondrocyte cultures. Cultures were enriched for
dark or light cells by treatment with 10% FCS or T3, respectively, until day 21 (A) or day 25 (B). Results for Sox9, aggrecan, CTGF, VEGF,
MMP-13 and FGFR3 expression in dark cell-enriched cultures are expressed relative to expression in light cell-enriched cultures. Results for
type II collagen (Coll-II) and Runx2 expression in light cell-enriched cultures are expressed relative to expression in dark cell-enriched cultures.
Data represent mean S.E.M.; n¼ 3. Signiﬁcant differences between values for light and dark cells are expressed as follows: a e P< 0.001;
b e P< 0.01.death. The modes of death undergone by the two cell types
were mutually exclusive, ruling out the possibility that they
represent stages of a single continuum: light chondrocytes
disintegrated by dismantling their cytoplasmic contents in-
side an intact plasma membrane, whereas dark chondro-
cytes disintegrated by breaking off packets of cytoplasmic
contents and plasma membrane.
In 2004, Roach et al.12 introduced the term ‘chondropto-
sis’ to the literature, describing the form of death that we
document here as typical of dark chondrocytes. We do
not consider this to be an appropriate name, partly because
of the implication that it is a form of apoptosis, and partly be-
cause as demonstrated here it represents only one of the
ways in which chondrocytes die. The mechanisms by which
light and dark hypertrophic chondrocytes die remain to be
determined. In their recent review, Shapiro et al.13 suggest
that hypertrophic chondrocytes die by autophagic cell
death, but we see no evidence in dying light or dark chon-
drocytes for the increased number of autophagosomes or
the nuclear changes typical of this form of cell death. The
disintegration of the cytoplasmic contents of light cells is
suggestive of non-lysosomal degradation1,2, but further
studies will be required to conﬁrm such a conclusion. It is
interesting to note that the example of this form of death
shown by Schweichel and Merker1 in their 1973 paper is
a typical light chondrocyte similar to those presented
here. Dark cells, in contrast, disintegrate by extrusion oftheir cytoplasmic contents (including secretory material) to-
gether with plasma membrane, until there is nothing but nu-
cleus left; this process appears to be morphologically
unique amongst modes of physiological cell death. Both
light and dark cells appeared to maintain a high level of pro-
tein synthesis and secretion almost until they had com-
pletely disintegrated, as judged by the presence of RER
and proteoglycan particles. In addition to proteoglycan,
the secretory material presumably also included proteolytic
enzymes such as MMP-13, which is expressed by hypertro-
phic chondrocytes and is essential for normal degradation
of the cartilage matrix at the ossiﬁcation front26,27. These
modes of death seem to be particularly well suited to cells
that need to remodel their surrounding matrix so as to assist
in the invasion of osteogenic cells (including blood vessels,
osteoclasts and osteoblasts), at the same time as they are
killing themselves.
Cells undergoing apoptosis are normally phagocytosed
by neighboring cells. The process of cellular condensation
and formation of apoptotic bodies followed by phagocytosis
is considered to be a mechanism for prevention of the in-
ﬂammation that would ensue if cytoplasmic contents were
released from dying cells. It seems that dark cells actually
do release their cytoplasmic contents as they die, which
as argued above is likely to assist in the necessary remod-
eling of the lacuna to allow invasion by osteogenic cells, but
may also act as a chemotactic stimulus for such cells.
584 Y. A. Ahmed et al.: Death of hypertrophic chondrocytesFig. 6. Effect of staurosporine on chondrocytes isolated from growth cartilage. Chondrocytes were cultured in monolayer (AeC) or pellet (DeF)
culture. Electron micrographs of cultures treated for 24 h in the presence (A, D) or absence (B, E) of staurosporine. Arrows indicate the nuclear
membrane, and arrowheads in A indicate aggregations of condensed chromatin typical of apoptosis. All micrographs have the same magni-
ﬁcation; bar¼ 2 mm. C, F: Dying dark chondrocytes (DDC), dying light chondrocytes (DLC) and apoptotic chondrocytes (APOP) were counted
and results expressed as a percentage of total cells. Data represent mean S.E.M.; a e signiﬁcant difference between treatment and control
(P< 0.001).Indeed, the invasion of these cells could perhaps be viewed
as a controlled inﬂammatory response. Phagocytosis is
clearly not possible for individual chondrocytes enclosed
in lacunae. There is evidence for phagocytosis by osteo-
clasts of chondrocyte remnants in open lacunae at the ossi-
ﬁcation front28; our observations do not contradict this idea,
but suggest that the chondrocytes have largely disinte-
grated by the time such phagocytosis occurs. Moreover,
Farnum and Wilsman29 have shown using serial sections
that a small proportion of terminal lacunae in porcine growth
cartilage are empty, indicating that some hypertrophic
chondrocytes are able to digest themselves completely
without the need for phagocytosis. We occasionally saw
phagocytosed remnants of apoptotic cells in chondrocyte
pellet cultures, but the phagocytic cells were elongated cells
at the periphery of the pellets, where cells were not sepa-
rated by large amounts of matrix, thus allowing contact
between cells that does not occur for more differentiated
chondrocytes.
The second aim of the current study was to develop a cul-
ture system in which the mechanism of physiological death
of hypertrophic chondrocytes could be studied. The pellet
culture system initially developed by Kato et al.21 was se-
lected for this purpose, since it allows chondrocytes to un-
dergo hypertrophy. In the current study, it has been
demonstrated that hypertrophic chondrocytes in pellet cul-
ture undergo the same forms of death as seen in growth
cartilage in vivo. Furthermore, it has been demonstrated
here that both the ratio of light:dark chondrocytes and the
proportion of dying cells can be manipulated by altering
the culture conditions. The effects of serum concentration
and factors previously shown to modulate chondrocytehypertrophy were investigated. TGF-b1 has been described
as exerting a variety of effects on chondrocytes, depending
on their state of differentiation. In monolayer culture where
chondrocytes undergo de-differentiation, TGF-b1 has
been reported to induce cell proliferation30. However, in pel-
let culture where chondrocytes maintain their differentiated
state, TGF-b1 has been reported to prevent hypertrophy31.
T3 has been shown to stimulate chondrocyte hypertrophy in
organ culture32. In the presence of a low serum concentra-
tion (0.1%), more cells were identiﬁable as light chondro-
cytes than dark chondrocytes, and a similar ratio was
seen with T3. In contrast, TGF-b1 or 10% FCS induced
most cells to become dark chondrocytes. The low serum
concentration was found to maintain survival up to 28
days in culture, whereas TGF-b1, T3 or 10% FCS acceler-
ated chondrocyte death. For each of these inducers of
chondrocyte death, the forms of death observed reﬂected
the ratio of light:dark chondrocytes present in the cultures.
Under all of these culture conditions, low proportions of cells
(less than 10%) underwent apoptosis.
Culture conditions found to induce either light or dark
chondrocyte differentiation were then used to compare
gene expression patterns in the two cell types, both early
and late in hypertrophy. Treatment with 10% FCS was
used to obtain an almost pure dark cell population, whereas
T3 treatment was used to obtain a light cell-enriched popu-
lation. The results of the qPCR analyses indicate that dark
cells express substantially higher levels of CTGF, VEGF
and MMP-13 than do light cells, and that the difference
increases as the cells begin to die. All of these gene prod-
ucts are known to be expressed by hypertrophic chondro-
cytes, and to play a variety of roles in endochondral
585Osteoarthritis and Cartilage Vol. 15, No. 5ossiﬁcation. CTGF stimulates chondrocyte hypertrophy33,
VEGF stimulates vascularization of the cartilage matrix34,
and MMP-13 is required for the degradation of collagen
within cartilage matrix26,27. In contrast, it appears that light
cells express signiﬁcantly higher levels of type II collagen
than do dark cells, both during early hypertrophy and death.
The cartilage-speciﬁc proteoglycan, aggrecan, appears to
be expressed at similar levels by both cell types. This is
the ﬁrst documentation of differences in gene expression
between light and dark hypertrophic chondrocytes.
Staurosporine induces apoptosis in a variety of cell types.
The experiment with staurosporine presented here was
conducted with the aim of inducing apoptosis in chondro-
cyte pellet culture; the intention was to establish culture
conditions in which the molecular mechanism of the modes
of death undergone by hypertrophic chondrocytes in vivo
could be compared with that of apoptosis. Surprisingly,
staurosporine did not induce apoptosis in chondrocytes in
pellet culture, but rather induced the death of dark chondro-
cytes by the mode of death typically seen in dark chondro-
cytes in vivo. Staurosporine did, however, induce apoptosis
in chondrocytes in monolayer culture, indicating that the
mode of death undergone by these cells is determined by
their three-dimensional environment and/or state of differ-
entiation, rather than by the nature of the death stimulus.
The fact that staurosporine accelerated the death of dark
but not light cells in pellet culture may suggest that dark
cell death shares a pathway with apoptosis that is not uti-
lized during light cell death.
In conclusion, the results presented here demonstrate
that light and dark hypertrophic chondrocytes undergo mor-
phologically distinct non-apoptotic modes of death in vivo.
These modes of death can be replicated in chondrocyte pel-
let cultures, and can be manipulated by varying serum con-
centration or treatment with TGF-b1, T3 or staurosporine.
This culture system will be useful for the further study of fac-
tors regulating death of hypertrophic chondrocytes, as well
as the molecular mechanisms by which light and dark chon-
drocytes die.
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